胸主动脉腔内修复术治疗主动脉溃疡的效果分析  

CLINICAL EFFECT OF THORACIC ENDOVASCULAR AORTIC REPAIR IN TREATMENT OF PENETRATING AORTIC ULCER

作　　者：刘春雨 李贞福[1] 何宇 张宏[1] 江磊[1] LIU Chunyu;LI Zhenfu;HE Yu;ZHANG Hong;JIANG Lei(Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266003, China)

机构地区：[1]青岛大学附属医院心血管外科,山东青岛266003

出　　处：《精准医学杂志》2020年第3期264-266,共3页Journal of Precision Medicine

基　　金：国家自然科学基金青年科学基金项目(81700247)。

摘　　要：目的探讨采用胸主动脉腔内修复术(TEVAR)治疗主动脉溃疡(PAU)患者的远期效果。方法选取2008年1月—2017年1月本院心血管外科经主动脉CT血管造影(CTA)确诊的PAU患者86例,根据患者的病情分为TEVAR治疗组(A组)67例和药物治疗组(B组)19例。记录两组患者年龄、性别、并发症、吸烟史、饮酒史、住院时间、随访结果等。结果所有患者住院期间均无死亡。A组的随访结果分级与B组比较差异具有显著意义(χ^2=2413.00,P<0.05);A组患者的中位生存时间与B组比较差异具有显著统计学意义(χ^2=2.28,P<0.05)。结论TEVAR治疗PAU患者安全有效,患者中位生存时间长,值得在临床推广应用。Objective To investigate the long-term clinical effect of thoracic endovascular aortic repair(TEVAR)in the treatment of penetrating aortic ulcer(PAU).Methods A total of 86 patients who were diagnosed with PAU by computed tomography angiography of the aorta in Department of Vascular Surgery in our hospital from January 2008 to January 2017 were enrolled,and according to their disease conditions,they were divided into group A(67 patients treated with TEVAR)and group B(19 patients treated with medication).Age,sex,complications,smoking history,drinking history,length of hospital stay,and follow-up results were recorded for both groups.Results No death was observed during hospitalization.There was a significant difference between group A and group B in the grading of follow-up results(χ^2=2413.00,P<0.05)and median survival time(χ^2=2.28,P<0.05).Conclusion TEVAR is safe and effective in the treatment of PAU and can achieve a long median survival time,and thus it holds promise for clinical application.

关 键 词：溃疡 主动脉疾病 胸主动脉腔内修复术 血管假体植入 主动脉 胸 药物疗法 治疗结果 

分 类 号：R543.1[医药卫生—心血管疾病] R654.3[医药卫生—内科学]